Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 1;44(4):281-286.
doi: 10.1097/INF.0000000000004622. Epub 2025 Mar 10.

The Prevalence, Serogroup Distribution and Risk Factors of Meningococcal Carriage in Children, Adolescents and Young Adults in Turkey Meningo-Carr-TR Study PART 3: COVID-19 Pandemic Situation

Mahmut Can Kizil  1 , Yalcin Kara  1 , Adem Karbuz  2 , Fatma Nur Oz  3 , Ergin Ciftci  4 , Zafer Kurugol  5 , Merve Iseri Nepesov  6 , Solmaz Celebi  7 , Benhur Sirvan Cetin  8 , Dilek Yilmaz  9 , Meltem Dinleyici  10 , Didem Kizmaz Isancli  2 , Onder Kilicaslan  2 , Halil Ozdemir  4 , Belkis Hatice Inceli  4 , Dondu Nilay Penezoglu  4 , Burce Dortkardesler  5 , Rabia G Sezer Yamanel  6 , Fatma Dilsad Aksoy  7 , Sedanur Tekin Can  8 , Nesli Agrali Eröz  9 , Mucahit Kaya  11 , Omer Kilic  1 , Ener Cagri Dinleyici  12
Affiliations

The Prevalence, Serogroup Distribution and Risk Factors of Meningococcal Carriage in Children, Adolescents and Young Adults in Turkey Meningo-Carr-TR Study PART 3: COVID-19 Pandemic Situation

Mahmut Can Kizil et al. Pediatr Infect Dis J. .

Abstract

Background: The prevalence of meningococcal carriage and serogroup distribution is crucial for assessing the epidemiology of invasive meningococcal disease, forecasting outbreaks and formulating potential immunization strategies. Following the meningococcal carriage studies conducted in Turkey in 2016 and 2018, we planned to re-evaluate meningococcal carriage in children, adolescents and young adults during the COVID-19 pandemic period.

Methods: In the MENINGO-CARR-3 study, we collected nasopharyngeal samples from 1585 participants 0-24 years of age, across 9 different centers in Turkey. We used polymerase chain reaction and serogroup distribution to determine how common it is for people to carry Neisseria meningitidis .

Results: The overall meningococcal carriage rate was 8.5% (n = 134). The serogroup distribution was as follows: serogroup A, 6%; serogroup B, 30.6%; serogroup W, 12.7%; serogroup Y, 3.7%; serogroup X, 1.5% and nongroupable as 45.5%. The highest carriage rate was found in 15-17-year-old adolescents (24.1%, 17.9%, and 20.2%, respectively). The carriage rate was higher among participants who had a previous COVID-19 infection ( P = 0.05; odds ratio: 1.95; 95% confidence interval: 1.11-3.44). The nasopharyngeal carriage rate was also higher than in the 2016 and 2018 studies (8.45% vs. 6.3% and 7.5%, respectively), and the most prevalent groupable serogroup was B during this study period, followed by serogroup W in 2016 and serogroup X in 2018.

Conclusions: The present study found that meningococcal carriage was higher during the post-COVID-19 pandemic period, especially in adolescents and young adults. Severe acute respiratory syndrome coronavirus-2 virus itself and/or pandemic mitigation strategies may affect both meningococcal carriage and serogroup distribution. Serogroup distribution varies between years, and further immunization strategies, including adolescent immunization, may play a role in controlling invasive meningococcal disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest regarding this study’s preparedness and publication. E.C.D. performs contract work for Eskisehir Osmangazi University funded by GSK, Pfizer, and Sanofi Pasteur, outside of this publication. M.K. is an employee of Diagen Biotechnology.

References

    1. Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321.
    1. Acevedo R, Bai X, Borrow R, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18:15–30.
    1. Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis (Lond). 2022;54:1–7.
    1. Balmer P, Burman C, Serra L, et al. Impact of meningococcal vaccination on carriage and disease transmission: a review of the literature. Hum Vaccin Immunother. 2018;14:1118–1130.
    1. Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:853–861.

MeSH terms